Prevention of Complications Due to Autonomic Dysreflexia in SCI Individuals

Sponsor
Assoc. Prof. Jiri Kriz, MD, PhD (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05024487
Collaborator
(none)
40
1
1
26.9
1.5

Study Details

Study Description

Brief Summary

Autonomic dysreflexia (AD) is a syndrome of unbalanced response of the sympathetic system to noxious stimuli below the level of spinal cord injury (SCI), characterized by paroxysmal hypertension. Mostly, it is combined with symptoms such as pounding headache, slowed heart rate, and upper body flushing, but it can also be asymptomatic. When resulting in hypertensive crisis, it can be life-threatening and result in seizures, cardiac arrest, retinal or subarachnoid hemorrhages, stroke, and even death.

The aim of this study is to determine the risk level of vascular complications in SCI people by correlating the clinical symptoms with their individual perception during AD triggered below the level of injury.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Clinical Examination
N/A

Detailed Description

After spinal cord injury, the disruption of descending vasomotor pathways to sympathetic neurons causes their hyperexcitability. When irritated by noxious stimuli below the level of injury, a massive sympathetic reflex is triggered, causing widespread vasoconstriction. If the neurological level of injury is at or above T6, this vasoconstriction can lead to progressive hypertension possibly involving the splanchnic vessels.

In response to hypertension, the baroreflex system lowers blood pressure by reducing heart rate and decreasing the activity of sympathetic neurons. However, a decrease in peripheral vascular resistance below the injury level does not occur because of the disruption of descending vasomotor pathways to sympathetic neurons. Thus, hypertension persists until the triggering stimulus is removed. Hypertensive crises can result in vascular complications like cardiac arrest, retinal or subarachnoid hemorrhages, stroke, and even death. Vasodilatation above the lesion level is accompanied by characteristic signs and symptoms such as upper body flushing and sweating, and a pounding headache. Sometimes bradyarrhythmia, seizures, nausea, or anxiety can occur. Unfortunately, AD can take place asymptomatically in almost 40 %. These asymptomatic individuals are at high risk of life-threatening complications mentioned above.

The most frequent AD triggers are overfilled bladder or bowel. Nevertheless, it can be any irritating stimuli below the level of injury, i.e., skin lacerations, ingrown toenails, or pressure sores.

Higher intensity of perception of clinical symptoms accompanying AD decreases the risk of vascular complications. People who perceive subjective signs of AD even in slightly elevated blood pressure can eliminate irritating stimuli or use an antihypertensive medication and thus avoid life-threatening complications. On contrary, people who cannot perceive the signs intensely enough are at a significantly higher risk of vascular complications.

The aim of this study is to determine the risk level of vascular complications in SCI people. The AD will be triggered below the injury level so that the clinical symptoms can be correlated with their subjective individual perception. Moreover, the development of a method allowing capturing AD episodes in individuals without subjective signs is intended.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Risk Level Determination of Vascular Complications Due to Autonomic Dysreflexia in Spinal Cord Injured Individuals
Anticipated Study Start Date :
Sep 1, 2021
Anticipated Primary Completion Date :
Sep 1, 2023
Anticipated Study Completion Date :
Nov 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental group

The correlation between blood pressure level, dermal resistance level, and subjective symptoms caused by triggered AD below the level of the lesion will be performed in a group of SCI people.

Diagnostic Test: Clinical Examination
Given the most frequent causes of AD, the above-mentioned trigger stimuli will be used. All these procedures are commonly used in SCI people.
Other Names:
  • Pinprick in sacral dermatome 4/5 (a part of International Standards for Neurological Classification of Spinal Cord Injury - ISNCSCI)
  • Deep Anal Pressure (a part of ISNCSCI)
  • Intermittent catheterization of the bladder
  • In absence of one of above-mentioned stimuli, stretching of hamstrings during elevation of legs will be performed
  • Outcome Measures

    Primary Outcome Measures

    1. Blood pressure monitoring [During the intervention]

      Continuous blood pressure and heart rate monitoring will be recorded using Finapres device. The risk level will be determined according to the value of systolic blood pressure (SBP): Low risk - SBP to 150 mmHg Moderate risk - SBP 150-200 mmHg High risk - SBP above 200 mmHg

    Secondary Outcome Measures

    1. Dermal sweating [During the intervention]

      Wrist sweating will be monitored using a measure of dermal resistance with range 0-5 MΩ (difference 0,1 kΩ, accuracy 0,15 %) and 5-32 MΩ (difference 10 kΩ, accuracy 1 %) and sampling frequency 10 second. Regarding the AD symptoms, level of dermal resistance decrease corresponds to increase of sweating.

    2. Assessment of symptoms [During the intervention]

      Subjective individual symptoms are divided into three groups, according to their severity (minimum value: mild symptoms, maximum: strong symptoms): Mild symptoms - shivers on the nape or on the back Moderate symptoms - sweating on the forehead, neck or upper extremities Strong symptoms - pounding headache, nausea

    3. ADFSCI questionnaire [During the intervention]

      The ADFSCI (Autonomic Dysfunction Following Spinal Cord Injury) questionnaire provides information about individual symptoms of blood pressure (BP) instability. The ADFSCI is a 24-item questionnaire consisting of four parts: demographics, medication, AD, and hypotension. The AD and hypotension parts include 10 and 7 items, respectively, each using a 5-point scale to score the frequency and severity of hyper- or hypotensive symptoms with a range of 0 ∼ 204 (highest BP instability) points.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 70 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • 18 to 70 years old female and male patients

    • People in chronic phase (more than 12 months) after traumatic or ischemic spinal cord lesion

    • People with Neurological Level of Injury C3-T6 and ASIA Impairment Scale A-B according to ISNCSCI

    • Written informed consent

    Exclusion Criteria:
    • People with acute infection or other suddenly incurred complication

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Department of Rehabilitation and Sports Medicine, University Hospital Motol Prague Czechia 150 06

    Sponsors and Collaborators

    • Assoc. Prof. Jiri Kriz, MD, PhD

    Investigators

    • Principal Investigator: Jiri Kriz, MD, PhD, Spinal Cord Unit, University Hospital Motol

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Assoc. Prof. Jiri Kriz, MD, PhD, Clinical Professor, University Hospital, Motol
    ClinicalTrials.gov Identifier:
    NCT05024487
    Other Study ID Numbers:
    • SCI_DYSREFLEXIA_2021
    First Posted:
    Aug 27, 2021
    Last Update Posted:
    Aug 27, 2021
    Last Verified:
    Aug 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Assoc. Prof. Jiri Kriz, MD, PhD, Clinical Professor, University Hospital, Motol
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 27, 2021